These compounds are broadly effective at reversing both TDP-43 mislocalization and stress-induced TDP-43 aggregation, in both familial and sporadic ALS and fronto-temporal dementia (FTD) cellular models. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.